145 related articles for article (PubMed ID: 37950164)
1. Subcategorization of suspicious non-mass-like enhancement lesions(BI-RADS-MRI Category4).
Liu D; Ba Z; Gao Y; Wang L
BMC Med Imaging; 2023 Nov; 23(1):182. PubMed ID: 37950164
[TBL] [Abstract][Full Text] [Related]
2. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
[TBL] [Abstract][Full Text] [Related]
3. Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.
Liu D; Ba Z; Ni X; Wang L; Yu D; Ma X
Med Sci Monit; 2018 Apr; 24():2180-2188. PubMed ID: 29644993
[TBL] [Abstract][Full Text] [Related]
4. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
5. Grading System to Categorize Breast MRI in BI-RADS 5th Edition: A Multivariate Study of Breast Mass Descriptors in Terms of Probability of Malignancy.
Fujiwara K; Yamada T; Kanemaki Y; Okamoto S; Kojima Y; Tsugawa K; Nakajima Y
AJR Am J Roentgenol; 2018 Mar; 210(3):W118-W127. PubMed ID: 29381382
[TBL] [Abstract][Full Text] [Related]
6. Subcategorization of Suspicious Breast Lesions (BI-RADS Category 4) According to MRI Criteria: Role of Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging.
Maltez de Almeida JR; Gomes AB; Barros TP; Fahel PE; de Seixas Rocha M
AJR Am J Roentgenol; 2015 Jul; 205(1):222-31. PubMed ID: 26102403
[TBL] [Abstract][Full Text] [Related]
7. A multiparametric classification system for lesions detected by breast magnetic resonance imaging.
Istomin A; Masarwah A; Okuma H; Sutela A; Vanninen R; Sudah M
Eur J Radiol; 2020 Nov; 132():109322. PubMed ID: 33045483
[TBL] [Abstract][Full Text] [Related]
8. The value of MRI for downgrading of breast suspicious lesions detected on ultrasound.
Xie Z; Xu W; Zhang H; Li L; An Y; Mao G
BMC Med Imaging; 2023 Jun; 23(1):72. PubMed ID: 37271827
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of MRI for architectural distortion categorized as BI-RADS category 3-4 by mammography.
Mei H; Xu J; Yao G; Wang Y
Gland Surg; 2020 Aug; 9(4):1008-1018. PubMed ID: 32953609
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
12. Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
Spinelli Varella MA; Teixeira da Cruz J; Rauber A; Varella IS; Fleck JF; Moreira LF
Clin Breast Cancer; 2018 Aug; 18(4):e507-e511. PubMed ID: 29066139
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
14. Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis.
Cui Q; Sun L; Zhang Y; Zhao Z; Li S; Liu Y; Ge H; Qin D; Zhao Y
Ann Transl Med; 2021 Nov; 9(22):1677. PubMed ID: 34988186
[TBL] [Abstract][Full Text] [Related]
15. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.
Perre SV; Duron L; Milon A; Bekhouche A; Balvay D; Cornelis FH; Fournier L; Thomassin-Naggara I
Eur Radiol; 2021 Jul; 31(7):4848-4859. PubMed ID: 33404696
[TBL] [Abstract][Full Text] [Related]
16. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
17. Differential Diagnosis of Breast Category 3 and 4 Nodules Through BI-RADS Classification in Conjunction with Shear Wave Elastography.
Wang M; Yang Z; Liu C; Yan J; Zhang W; Sun J; Cui G
Ultrasound Med Biol; 2017 Mar; 43(3):601-606. PubMed ID: 27988221
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
[TBL] [Abstract][Full Text] [Related]
19. Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions.
Iima M; Kataoka M; Kanao S; Onishi N; Kawai M; Ohashi A; Sakaguchi R; Toi M; Togashi K
Radiology; 2018 May; 287(2):432-441. PubMed ID: 29095673
[TBL] [Abstract][Full Text] [Related]
20. Grading system to categorize breast MRI using BI-RADS 5th edition: a statistical study of non-mass enhancement descriptors in terms of probability of malignancy.
Asada T; Yamada T; Kanemaki Y; Fujiwara K; Okamoto S; Nakajima Y
Jpn J Radiol; 2018 Mar; 36(3):200-208. PubMed ID: 29285740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
